Skip to main content
Log in

Male breast uptake in rubidium-82 PET due to spironolactone-induced gynecomastia

  • Images that Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

References

  1. Wang HY, Jeng LB, Lin MC, et al. 18-F FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma. Clin Imaging 2013;37(5):942-6.

    Article  PubMed  Google Scholar 

  2. Rose LI, Underwood RH, Newmark SR, et al. Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 1977;87:398-403.

    Article  CAS  PubMed  Google Scholar 

  3. Unzek S, Galla J, Cerqueira M, Jaber WA. Tc-99m tetrofosmin uptake in a male patient with gynecomastia. J Nucl Cardiol 2007;14:902-3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. L. Kiehl MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiehl, E.L., Shivapour, D.M., Goenka, A.H. et al. Male breast uptake in rubidium-82 PET due to spironolactone-induced gynecomastia. J. Nucl. Cardiol. 22, 1148–1150 (2015). https://doi.org/10.1007/s12350-014-0042-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-014-0042-y

Keywords

Navigation